|
POLDIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.761980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.366650E-01 |
| Normal-vs-Stage2 |
9.352800E-01 |
| Normal-vs-Stage3 |
8.725600E-01 |
| Normal-vs-Stage4 |
7.420000E-01 |
| Stage1-vs-Stage2 |
4.354800E-01 |
| Stage1-vs-Stage3 |
4.935000E-01 |
| Stage1-vs-Stage4 |
8.443400E-01 |
| Stage2-vs-Stage3 |
8.564800E-01 |
| Stage2-vs-Stage4 |
7.196000E-01 |
| Stage3-vs-Stage4 |
8.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.265570E-01 |
| Normal-vs-AfricanAmerican |
9.359400E-01 |
| Normal-vs-Asian |
5.724800E-01 |
| Caucasian-vs-AfricanAmerican |
1.774790E-01 |
| Caucasian-vs-Asian |
6.312600E-01 |
| AfricanAmerican-vs-Asian |
5.648000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.548580E-01 |
| Normal-vs-Female |
5.361600E-01 |
| Male-vs-Female |
6.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.274000E-01 |
| Normal-vs-Extreme_Weight |
5.817800E-01 |
| Normal-vs-Obese |
4.740600E-01 |
| Normal-vs-Extreme_Obese |
6.978100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.298600E-01 |
| Normal_Weight-vs-Obese |
2.707200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.196100E-02 |
| Extreme_Weight-vs-Obese |
8.606200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.096000E-02 |
| Obese-vs-Extreme_Obese |
1.019640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.872400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.454400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.785600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.159980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.939800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.701970E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.033760E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.058800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.916300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.852580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.359400E-04 |
| Normal-VS-Type2 PRCC |
8.147600E-01 |
| Normal-VS-KIRP CIMP |
8.543000E-01 |
| Normal-VS-Unclassified PRCC |
9.602000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.321650E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.702150E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.442200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.621800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.973800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.804800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.582200E-01 |
| Normal-vs-N1 |
2.890400E-01 |
| Normal-vs-N2 |
2.868300E-02 |
| N0-vs-N1 |
1.621030E-01 |
| N0-vs-N2 |
1.196970E-03 |
| N1-vs-N2 |
1.831200E-01 |
|
|
